 To demonstrate that the hexavalent DTaP-IPV-HB-PRPT combined vaccine induces an immune response that is at least as good as the response following InfanrixTM-Hexa in terms of seroprotection rates to HB and PRP, one month after a 3 dose primary series 2, 4, and 6 months, when co-administered with Prevnar 